litlas
Log inCreate account

Lars Gullestad

Active 1997–2025

144
Papers
20,857
Citations
83
h-index
133
i10-index

Citations

Citations per year for Lars Gullestad1983: 1 citations1992: 1 citations1994: 1 citations1996: 1 citations1997: 3 citations1998: 5 citations1999: 19 citations2000: 37 citations2001: 73 citations2002: 86 citations2003: 93 citations2004: 121 citations2005: 123 citations2006: 118 citations2007: 93 citations2008: 141 citations2009: 136 citations2010: 144 citations2011: 152 citations2012: 176 citations2013: 157 citations2014: 154 citations2015: 144 citations2016: 137 citations2017: 163 citations2018: 135 citations2019: 538 citations2020: 555 citations2021: 571 citations2022: 546 citations2023: 427 citations2024: 651 citations2025: 403 citations2026: 8 citations1984–1991: no citations, so these years are not shown1993: no citations, so this year is not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,857 citing papers, 19.1% of this breakdownUnited Kingdom: 702 citing papers, 7.2% of this breakdownChina: 689 citing papers, 7.1% of this breakdownItaly: 673 citing papers, 6.9% of this breakdownGermany: 637 citing papers, 6.6% of this breakdownNetherlands: 407 citing papers, 4.2% of this breakdownCanada: 333 citing papers, 3.4% of this breakdownFrance: 324 citing papers, 3.4% of this breakdownNorway: 294 citing papers, 3% of this breakdownSpain: 285 citing papers, 3% of this breakdownSweden: 274 citing papers, 2.8% of this breakdownAustralia: 235 citing papers, 2.4% of this breakdown
0%19.1%Other 30.9%

Institutions

Fields

  • Medicine68.8%
  • Biochemistry, Genetics and Molecular Biology17.3%
  • Immunology and Microbiology9.1%
  • Nursing1.4%
  • Neuroscience1.2%
  • Engineering0.7%
  • Other1.5%

Topics

  • Heart Failure Treatment and Management6.2%
  • Cardiovascular Function and Risk Factors4.7%
  • Cardiac Fibrosis and Remodeling4%
  • Adipokines, Inflammation, and Metabolic Diseases2.9%
  • Atherosclerosis and Cardiovascular Diseases2.9%
  • Lipoproteins and Cardiovascular Health2.1%
  • Other77.2%

Coauthors

All papers

Open in search
  1. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction

    Authors: Kaspar Broch, Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, Ingvild Maria Tøllefsen, Bjørn Bendz, Svend Aakhus, Thor Ueland, Brage H. Amundsen, Jan Kristian Damås, Erlend Sturle Berg, Elisabeth Bjørkelund, Christina Bendz, Einar Hopp, Ola Kleveland, Knut Haakon Stensæth, Anders Opdahl, Nils‐Einar Kløw, Ingebjørg Seljeflot, Geir Øystein Andersen, Rune Wiseth, Pål Aukrust, Lars Gullestad - Journal of the American College of Cardiology 2021 cited by 410

  2. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

    Authors: Ola Kleveland, Gabor Kunszt, Marte Bratlie, Thor Ueland, Kaspar Broch, Espen Holte, Annika E. Michelsen, Bjørn Bendz, Brage H. Amundsen, Terje Espevik, Svend Aakhus, Jan Kristian Damås, Pål Aukrust, Rune Wiseth, Lars Gullestad - European Heart Journal 2016 cited by 378

  3. Targeting the Inflammasome in Cardiovascular Disease

    Authors: Maria Belland Olsen, Ida Gregersen, Øystein Sandanger, Kuan Yang, Marina Sokolova, Bente Evy Halvorsen, Lars Gullestad, Kaspar Broch, Pål Aukrust, Mieke C. Louwe - JACC Basic to Translational Science 2021 cited by 159

  4. Rosuvastatin in Older Patients with Systolic Heart Failure

    Authors: John Kjekshus, Eduard Apetrei, Vivencio Barrios, Michael Böhm, John G.F. Cleland, Jan H. Cornel, Peter Dunselman, Cândida Fonseca, Assen Goudev, Peer Grande, Lars Gullestad, Åke Hjalmarson, J Hradec, András Jánosi, Gabriel Kamenský, Michel Komajda, J Korewicki, Timo Kuusi, François Mach, Vyacheslav Mareev, John J.V. McMurray, Naresh Ranjith, Maria Schaufelberger, Johan Vanhaecke, Dirk J. van Veldhuisen, Finn Waagstein, Hans Wedel, John Wikstrand - New England Journal of Medicine 2007 cited by 1,493

  5. Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes

    Authors: William T. Abraham, JoAnn Lindenfeld, Piotr Ponikowski, Piergiuseppe Agostoni, Javed Butler, Akshay S. Desai, Gerasimos Filippatos, Jacek Gniot, Michael Fu, Lars Gullestad, Jonathan G. Howlett, Stephen J. Nicholls, Josep Redón, Isabelle Schenkenberger, José Silva‐Cardoso, Stefan Störk, Jerzy Krzysztof Wranicz, Gianluigi Savarese, Martina Brueckmann, Waheed Jamal, Matias Nordaby, Barbara Peil, Ivana Ritter, Anastasia Ustyugova, Cordula Zeller, Afshin Salsali, Stefan D. Anker - European Heart Journal 2020 cited by 212

  6. A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

    Authors: George Dangas, Jan G.P. Tijssen, Jochen Wöhrle, Lars Søndergaard, Martine Gilard, Helge Möllmann, Raj Makkar, Howard C. Herrmann, Gennaro Giustino, Stephan Baldus, Ole De Backer, Ana H.C. Guimarães, Lars Gullestad, Annapoorna Kini, Dirk von Lewinski, Michael J. Mack, Raúl Moreno, Ulrich Schäfer, Julia Seeger, Didier Tchétché, Karen Thomitzek, Marco Valgimigli, Pascal Vranckx, Robert C. Welsh, Peter Wildgoose, Albert A. Volkl, Ana Denise Zazula, R.G.M. van Amsterdam, Roxana Mehran, Stephan Windecker - New England Journal of Medicine 2019 cited by 542

  7. Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure

    Authors: Cristiane C.K. Mayerhofer, Thor Ueland, Kaspar Broch, Royce P Vincent, Gemma F. Cross, Christen P. Dahl, Pål Aukrust, Lars Gullestad, Johannes R. Hov, Marius Trøseid - Journal of Cardiac Failure 2017 cited by 163

  8. Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

    Authors: Marius Trøseid, Thor Ueland, Johannes R. Hov, Asbjørn Svardal, Ida Gregersen, C. P. Dahl, Svend Aakhus, E. Gude, Bodil Bjørndal, Bente Halvorsen, Tom H. Karlsen, Pål Aukrust, Lars Gullestad, Rolf K. Berge, Arne Yndestad - Journal of Internal Medicine 2014 cited by 470

  9. Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial

    Authors: Gunn Marit Traaen, Lars Aakerøy, Tove-Elizabeth Hunt, Britt Øverland, Christina Bendz, Lars Øivind Sande, Svend Aakhus, Morten Wang Fagerland, Sigurd Steinshamn, Ole‐Gunnar Anfinsen, Richard J. Massey, Kaspar Broch, Thor Ueland, Harriet Akre, Jan Pål Loennechen, Lars Gullestad - American Journal of Respiratory and Critical Care Medicine 2021 cited by 110

  10. EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

    Authors: Aldo P. Maggioni, Ulf Dahlström, Gerasimos Filippatos, Ovidiu Chioncel, Marisa Crespo Leiro, Jarosław Dróżdż, Friedrich Fruhwald, Lars Gullestad, Damien Logeart, Gianna Fabbri, Renato Urso, Marco Metra, John Parissis, Hans Lennart Persson, Piotr Ponikowski, Mathias Rauchhaus, Adriaan A. Voors, Olav Wendelboe Nielsen, Faı̈ez Zannad, Luigi Tavazzi - European Journal of Heart Failure 2013 cited by 801

  11. Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction

    Authors: Michael Frisk, Christopher Le, Xin Shen, Åsmund T. Røe, Yufeng Hou, Ornella Manfra, Gustavo José Justo da Silva, Isabelle van Hout, Einar Sjaastad Nordén, Jan Magnus Aronsen, Martin Laasmaa, Emil Knut Stenersen Espe, Fouad A. Zouein, Regis R. Lambert, Christen P. Dahl, Ivar Sjaastad, Ida G. Lunde, Sean Coffey, Alessandro Cataliotti, Lars Gullestad, Theis Tønnessen, Peter P. Jones, Raffaele Altara, William E. Louch - Journal of the American College of Cardiology 2021 cited by 125

  12. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial

    Authors: Nicolai Tegn, Michael Abdelnoor, Lars Aaberge, Knut Endresen, Pål Smith, Svend Aakhus, Erik Gjertsen, Ola Dahl-Hofseth, Anette Hylen Ranhoff, Lars Gullestad, Bjørn Bendz - The Lancet 2016 cited by 441

  13. Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure

    Authors: Åke Hjalmarson, Sidney Goldstein, Björn Fagerberg, Hans Wedel, Finn Waagstein, John Kjekshus, John Wikstrand, Dia El Allaf, Jiří Vítovec, Jan Aldershvile, Matti Halinen, Rainer Dietz, Karl-Ludwig Neuhaus, András Jánosi, Guðmundur Þorgeirsson, Peter H.J.M. Dunselman, Lars Gullestad, J Kuch, Johan Herlitz, Peter Rickenbacher, Stephen Ball, Stephen S. Gottlieb, Prakash Deedwania, for the MERIT-HF Study Group - JAMA 2000 cited by 1,394

  14. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial

    Authors: Ayodeji Awoyemi, Cristiane C.K. Mayerhofer, Alex S. Felix, Johannes R. Hov, Samuel Datum Moscavitch, Knut Tore Lappegård, Anders Hovland, Sigrun Halvorsen, Bente Halvorsen, Ida Gregersen, Asbjørn Svardal, Rolf K. Berge, Simen H. Hansen, Alexandra Götz, Kristian Holm, Pål Aukrust, Sissel Åkra, Ingebjørg Seljeflot, Svein Solheim, Andrea De Lorenzo, Lars Gullestad, Marius Trøseid, Kaspar Broch - EBioMedicine 2021 cited by 87

  15. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T

    Authors: Michele Emdin, Alberto Aimo, Giuseppe Vergaro, Antoni Bayés‐Genís, Josep Lupón, Roberto Latini, Jennifer Meessen, Inder S. Anand, Jay N. Cohn, Jørgen Gravning, Lars Gullestad, Kaspar Broch, Thor Ueland, Ståle H. Nymo, Hans‐Peter Brunner‐La Rocca, Rudolf A. de Boer, Hanna K. Gaggin, Andrea Ripoli, Claudio Passino, James L. Januzzi - Journal of the American College of Cardiology 2018 cited by 213

  16. Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial

    Authors: Tove-Elizabeth Hunt, Gunn Marit Traaen, Lars Aakerøy, Christina Bendz, Britt Øverland, Harriet Akre, Sigurd Steinshamn, Jan Pål Loennechen, Finn Hegbom, Kaspar Broch, Øyvind Lie, Erik Lyseggen, Kristina H. Haugaa, Lars Gullestad, Ole‐Gunnar Anfinsen - Heart Rhythm 2022 cited by 70

  17. Rosuvastatin alters the genetic composition of the human gut microbiome

    Authors: Martin Kummen, Ole Geir Solberg, Christopher Storm-Larsen, Kristian Holm, Asgrimur Ragnarsson, Marius Trøseid, Beate Vestad, Rita Skårdal, Arne Yndestad, Thor Ueland, Asbjørn Svardal, Rolf K. Berge, Ingebjørg Seljeflot, Lars Gullestad, Tom H. Karlsen, Lars Aaberge, Pål Aukrust, Johannes R. Hov - Scientific Reports 2020 cited by 58

  18. Inflammatory Cytokines in Heart Failure: Mediators and Markers

    Authors: Lars Gullestad, Thor Ueland, Leif Erik Vinge, Alexandra Vanessa Finsen, Arne Yndestad, Pål Aukrust - Cardiology 2012 cited by 353

  19. Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis

    Authors: Savvina Prapiadou, Luka Živković, Barbara Thorand, Marc J. George, Sander W. van der Laan, Rainer Malik, Christian Herder, Wolfgang Köenig, Thor Ueland, Ola Kleveland, Pål Aukrust, Lars Gullestad, Jürgen Bernhagen, Gerard Pasterkamp, Annette Peters, Aroon D. Hingorani, Jonathan Rosand, Martin Dichgans, Christopher D. Anderson, Marios K. Georgakis - Circulation 2023 cited by 51

  20. Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial

    Authors: Camilla Huse, Anne Kristine Anstensrud, Annika E. Michelsen, Thor Ueland, Kaspar Broch, Sindre Woxholt, Kuan Yang, Kapil Sharma, Ingvild Maria Tøllefsen, Bjørn Bendz, Brage H. Amundsen, Jan Kristian Damås, Erlend Sturle Berg, Elisabeth Bjørkelund, Ana Quiles‐Jiménez, Vigdis Bjerkeli, Christina Bendz, Ola Kleveland, Knut Haakon Stensæth, Anders Opdahl, Nils‐Einar Kløw, Geir Øystein Andersen, Rune Wiseth, Bente Halvorsen, Lars Gullestad, Ingebjørg Seljeflot, Pål Aukrust, Liv Osnes, Tuva B. Dahl - EBioMedicine 2022 cited by 51

  21. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis

    Authors: Nathalie Niyonzima, Siril S. Bakke, Ida Gregersen, Sverre Holm, Øystein Sandanger, Hilde L. Orrem, Bjørnar Sporsheim, Liv Ryan, Xiang Yi Kong, Tuva B. Dahl, Mona Skjelland, Kirsten Krohg Sørensen, Anne Mari Rokstad, Arne Yndestad, Eicke Latz, Lars Gullestad, Geir Øystein Andersen, Jan Kristian Damås, Pål Aukrust, Tom Eirik Mollnes, Bente Halvorsen, Terje Espevik - EBioMedicine 2020 cited by 82

  22. Machine Learning for Sleep Apnea Detection with Unattended Sleep Monitoring at Home

    Authors: Stein Kristiansen, Konstantinos Nikolaidis, Thomas Plagemann, Vera Goebel, Gunn Marit Traaen, Britt Øverland, Lars Aakerøy, Tove-Elizabeth Hunt, Jan Pål Loennechen, Sigurd Loe Steinshamn, Christina Holt Bendz, Ole-Gunnar Anfinsen, Lars Gullestad, Harriet Akre - ACM Transactions on Computing for Healthcare, ACM Trans. Comput. Heal. 2021 cited by 35

  23. Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure

    Authors: Pål Aukrust, Thor Ueland, Fredrik Müller, Arne K. Andreassen, Ingvild Nordøy, Halfdan Aas, John Kjekshus, Svein Simonsen, Stig S. Frøland, Lars Gullestad - Circulation 1998 cited by 370

  24. Elevated Levels of Activin A in Heart Failure

    Authors: Arne Yndestad, Thor Ueland, Erik Øie, Geir Florholmen, Bente Halvorsen, Håvard Attramadal, Svein Simonsen, Stig S. Frøland, Lars Gullestad, Geir Christensen, Jan Kristian Damås, Pål Aukrust - Circulation 2004 cited by 177